Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin d1

• Published in: PloS one Vol. 10; no. 1; p. e0116543
• Main Authors: Musto, Alberto E, Walker, Chelsey P, Petasis, Nicos A, Bazan, Nicolas G
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 24.01.2015; Public Library of Science (PLoS)
• Subjects: Aberration; Animals; Biological activity; Cellular communication; Dendritic spines; Dendritic Spines - drug effects; Dendritic Spines - pathology; Docosahexaenoic acid; Docosahexaenoic Acids - pharmacology; Drug dosages; Epilepsy; Epilepsy, Temporal Lobe - pathology; Epilepsy, Temporal Lobe - physiopathology; Fatty acids; Health sciences; Hippocampus; House mouse; Limbic System - drug effects; Limbic System - pathology; Male; Medicin och hälsovetenskap; Mice; Mice, Inbred C57BL; Microelectrodes; Nerve Net - drug effects; Neural networks; Neuroprotection; Neurosciences; Omega 3 fatty acids; Pilocarpine; Rodents; Seizures; Seizures (Medicine); Signaling; Silicon; Status Epilepticus - chemically induced; Status Epilepticus - drug therapy; Status Epilepticus - pathology; Stratum radiatum; Temporal lobe; Unsaturated fatty acids
• DOI: 10.1371/journal.pone.0116543
• ISSN: 1932-6203

Limbic epileptogenesis triggers molecular and cellular events that foster the establishment of aberrant neuronal networks that, in turn, contribute to temporal lobe epilepsy (TLE). Here we have examined hippocampal neuronal network activities in the pilocarpine post-status epilepticus model of limbic epileptogenesis and asked whether or not the docosahexaenoic acid (DHA)-derived lipid mediator, neuroprotectin D1 (NPD1), modulates epileptogenesis. Status epilepticus (SE) was induced by intraperitoneal administration of pilocarpine in adult male C57BL/6 mice. To evaluate simultaneous hippocampal neuronal networks, local field potentials were recorded from multi-microelectrode arrays (silicon probe) chronically implanted in the dorsal hippocampus. NPD1 (570 μg/kg) or vehicle was administered intraperitoneally daily for five consecutive days 24 hours after termination of SE. Seizures and epileptiform activity were analyzed in freely-moving control and treated mice during epileptogenesis and epileptic periods. Then hippocampal dendritic spines were evaluated using Golgi-staining. We found brief spontaneous microepileptiform activity with high amplitudes in the CA1 pyramidal and stratum radiatum in epileptogenesis. These aberrant activities were attenuated following systemic NPD1 administration, with concomitant hippocampal dendritic spine protection. Moreover, NPD1 treatment led to a reduction in spontaneous recurrent seizures. Our results indicate that NPD1 displays neuroprotective bioactivity on the hippocampal neuronal network ensemble that mediates aberrant circuit activity during epileptogenesis. Insight into the molecular signaling mediated by neuroprotective bioactivity of NPD1 on neuronal network dysfunction may contribute to the development of anti-epileptogenic therapeutic strategies.